Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial.

Morris, W James; Pickles, Tom; Keyes, Mira

Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial.

Morris, W James; Pickles, Tom; Keyes, Mira.

Afiliación

Morris WJ; Clinical Professor, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Radiation Oncologist, Vancouver Cancer Centre, Vancouver, British Columbia, Canada. Electronic address: jmorris@bccancer.bc.ca.
Pickles T; Clinical Professor, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Radiation Oncologist, Vancouver Cancer Centre, Vancouver, British Columbia, Canada.
Keyes M; Clinical Professor, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Radiation Oncologist, Vancouver Cancer Centre, Vancouver, British Columbia, Canada.

Brachytherapy ; 17(6): 837-844, 2018.

Article en En | MEDLINE | ID: mdl-30245169

Asunto(s)

Antagonistas de Andrógenos/administración & dosificación; Braquiterapia/métodos; Antígeno Prostático Específico/análisis; Neoplasias de la Próstata/radioterapia; Anciano; Braquiterapia/efectos adversos; Humanos; Masculino; Persona de Mediana Edad; Recurrencia Local de Neoplasia/sangre; Antígeno Prostático Específico/sangre; Neoplasias de la Próstata/sangre; Neoplasias de la Próstata/mortalidad; Dosificación Radioterapéutica; Análisis de Supervivencia; Insuficiencia del Tratamiento

Palabras clave

Brachytherapy; PSA relapse; Prostate cancer; Surgical prostatectomy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia / Antígeno Prostático Específico / Antagonistas de Andrógenos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Brachytherapy Asunto de la revista: RADIOTERAPIA Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google